Episode Details
Back to Episodes
Episode 45: Getting Drug Approval Through FDA LPAD
Published 6 years, 5 months ago
Description
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, some ideas that he spoke about on the recent NORD panel about innovative and ethical partnerships, and Insmed’s pipeline and progress.